Video
Asia-Pacific's healthcare private equity market had a record year in 2020, with the pandemic accelerating the push for innovation. Vikram Kapur and Kevin Chang, partners in Bain's Private Equity practice, discuss how biopharma and medtech have emerged as the busiest and most innovative subsectors in the region.
Healthcare Private Equity in Asia-Pacific: Riding a Wave of Domestic Innovation
Investors see underserved demand and favorable shifts in healthcare policies.
First published in abril 2021